Methyl 3-bromo-5-methylbenzoate

Catalog No.: 
ACCBRA321
CAS No.: 
478375-40-5
Molecular Formula: 
C9H9BrO2
Molecular Weight: 
229.07
Methyl 3-bromo-5-methylbenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$102.00In stockIn stock
100g97%$400.00In stockIn stock
500g97%$1598.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-bromo-5-methylbenzoate
IUPAC Namemethyl 3-bromo-5-methylbenzoate
MDL No.MFCD11007827
Molecular FormulaC9H9BrO2
Molecular Weight229.07
SMILESO=C(OC)C1=CC(C)=CC(Br)=C1
InChI KeyOAOZBFUAVJUPED-UHFFFAOYSA-N
SynonymMethyl 3-bromo-5-methylbenzoate | 478375-40-5 | 3-Bromo-5-methyl-benzoic acid methyl ester | 3-Bromo-5-methylbenzoic acid methyl ester | MFCD11007827 | Benzoic acid, 3-bromo-5-methyl-, methyl ester | SCHEMBL839253 | Methyl3-bromo-5-methylbenzoate | DTXSID90626930 | OAOZBFU
CAS No.478375-40-5
PubChem CID22613903

Synthetic Route by SureRoute

1. ACCBRA321 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTPIQ230 route compound structure diagram
    ACTPIQ23058530-13-5In Stock
  2. Then
  3. ACCBRA321 route product structure diagram
    ACCBRA321478375-40-5In Stock
Inquiry

2. ACCBRA321 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACTPIQ230 route compound structure diagram
    ACTPIQ23058530-13-5In Stock
  4. Then
  5. ACCBRA321 route product structure diagram
    ACCBRA321478375-40-5In Stock
Inquiry

3. ACCBRA321 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTPIQ230 route compound structure diagram
    ACTPIQ23058530-13-5In Stock
  4. Then
  5. ACCBRA321 route product structure diagram
    ACCBRA321478375-40-5In Stock
Inquiry

Comments (0)